166 related articles for article (PubMed ID: 25103454)
1. Multiple primary (even in situ) melanomas in a patient pose significant risk to family members.
Chen T; Hemminki K; Kharazmi E; Ji J; Sundquist K; Fallah M
Eur J Cancer; 2014 Oct; 50(15):2659-67. PubMed ID: 25103454
[TBL] [Abstract][Full Text] [Related]
2. Incidence trends and familial risks in invasive and in situ cutaneous melanoma by sun-exposed body sites.
Hemminki K; Zhang H; Czene K
Int J Cancer; 2003 May; 104(6):764-71. PubMed ID: 12640685
[TBL] [Abstract][Full Text] [Related]
3. Familial and attributable risks in cutaneous melanoma: effects of proband and age.
Hemminki K; Zhang H; Czene K
J Invest Dermatol; 2003 Feb; 120(2):217-23. PubMed ID: 12542525
[TBL] [Abstract][Full Text] [Related]
4. [Increased incidence of multiple melanoma in sporadic and familial dysplastic nevus cell syndrome].
Sigg C; Pelloni F; Schnyder UW
Hautarzt; 1989 Sep; 40(9):548-52. PubMed ID: 2807914
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of and risk factors for multiple primary melanomas.
Ferrone CR; Ben Porat L; Panageas KS; Berwick M; Halpern AC; Patel A; Coit DG
JAMA; 2005 Oct; 294(13):1647-54. PubMed ID: 16204664
[TBL] [Abstract][Full Text] [Related]
6. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers.
Dong C; Hemminki K
Int J Cancer; 2001 Jun; 92(6):883-7. PubMed ID: 11351311
[TBL] [Abstract][Full Text] [Related]
7. Familial risk of cancer shortly after diagnosis of the first familial tumor.
Bermejo JL; Hemminki K
J Natl Cancer Inst; 2005 Nov; 97(21):1575-9. PubMed ID: 16264177
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of bias in familial risk estimates: a study of common cancers using Swedish population-based registers.
Leu M; Reilly M; Czene K
J Natl Cancer Inst; 2008 Sep; 100(18):1318-25. PubMed ID: 18780865
[TBL] [Abstract][Full Text] [Related]
9. Familial risks for eye melanoma and retinoblastoma: results from the Swedish Family-Cancer Database.
Hemminki K; Chen B
Melanoma Res; 2006 Apr; 16(2):191-5. PubMed ID: 16567975
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of familial cutaneous melanoma.
Hemminki K; Lönnstedt I; Vaittinen P
Melanoma Res; 2001 Apr; 11(2):133-40. PubMed ID: 11333122
[TBL] [Abstract][Full Text] [Related]
11. [Family studies on the incidence of multiple pigmented naevi, familial skin melanoma and other malignant tumors].
Szekeres L; Korom I
Orv Hetil; 1991 Sep; 132(39):2153-6. PubMed ID: 1923488
[TBL] [Abstract][Full Text] [Related]
12. Population-based analysis of prognostic factors and survival in familial melanoma.
Florell SR; Boucher KM; Garibotti G; Astle J; Kerber R; Mineau G; Wiggins C; Noyes RD; Tsodikov A; Cannon-Albright LA; Zone JJ; Samlowski WE; Leachman SA
J Clin Oncol; 2005 Oct; 23(28):7168-77. PubMed ID: 16192601
[TBL] [Abstract][Full Text] [Related]
13. Role of the CDKN2A locus in patients with multiple primary melanomas.
Puig S; Malvehy J; Badenas C; Ruiz A; Jimenez D; Cuellar F; Azon A; Gonzàlez U; Castel T; Campoy A; Herrero J; Martí R; Brunet-Vidal J; Milà M
J Clin Oncol; 2005 May; 23(13):3043-51. PubMed ID: 15860862
[TBL] [Abstract][Full Text] [Related]
14. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia).
Siskind V; Whiteman DC; Aitken JF; Martin NG; Green AC
Cancer Causes Control; 2005 Apr; 16(3):193-9. PubMed ID: 15947871
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.
Hansson J; Bergenmar M; Hofer PA; Lundell G; Månsson-Brahme E; Ringborg U; Synnerstad I; Bratel AT; Wennberg AM; Rosdahl I
J Clin Oncol; 2007 Jul; 25(19):2819-24. PubMed ID: 17602087
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
[TBL] [Abstract][Full Text] [Related]
17. Multiple primary melanomas.
Johnson TM; Hamilton T; Lowe L
J Am Acad Dermatol; 1998 Sep; 39(3):422-7. PubMed ID: 9738776
[TBL] [Abstract][Full Text] [Related]
18. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
[TBL] [Abstract][Full Text] [Related]
19. CDKN2A mutations in multiple primary melanomas.
Monzon J; Liu L; Brill H; Goldstein AM; Tucker MA; From L; McLaughlin J; Hogg D; Lassam NJ
N Engl J Med; 1998 Mar; 338(13):879-87. PubMed ID: 9516223
[TBL] [Abstract][Full Text] [Related]
20. Thick melanoma: the challenge persists.
Murray CS; Stockton DL; Doherty VR
Br J Dermatol; 2005 Jan; 152(1):104-9. PubMed ID: 15656809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
